(19)
(11) EP 4 578 019 A1

(12)

(43) Date of publication:
02.07.2025 Bulletin 2025/27

(21) Application number: 23858349.6

(22) Date of filing: 25.08.2023
(51) International Patent Classification (IPC): 
G16B 20/00(2019.01)
G16B 20/20(2019.01)
G06N 20/00(2019.01)
G16H 10/40(2018.01)
C12Q 1/6883(2018.01)
G16B 40/00(2019.01)
C12Q 1/6869(2018.01)
(52) Cooperative Patent Classification (CPC):
G16B 20/10; G16B 40/20; G16B 30/00; G16H 50/30; G06N 20/20; G06N 5/01; G06N 7/01
(86) International application number:
PCT/US2023/072909
(87) International publication number:
WO 2024/044749 (29.02.2024 Gazette 2024/09)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 26.08.2022 US 202263401547 P

(71) Applicants:
  • Fred Hutchinson Cancer Center
    Seattle, WA 98109 (US)
  • University of Washington
    Seattle, WA 98195 (US)

(72) Inventors:
  • ADIL, Mohamed
    Seattle, Washington 98195 (US)
  • HA, Gavin
    Seattle, Washington 98109 (US)
  • REICHEL, Jonathan Brett
    Seattle, Washington 98195 (US)
  • LOCKWOOD, Christina M.
    Seattle, Washington 98195 (US)
  • SHREE, Raj
    Seattle, Washington 98195 (US)

(74) Representative: J A Kemp LLP 
80 Turnmill Street
London EC1M 5QU
London EC1M 5QU (GB)

   


(54) CELL-FREE DNA SEQUENCE DATA ANALYSIS TECHNIQUES FOR ESTIMATING FETAL FRACTION AND PREDICTING PREECLAMPSIA